Sign Out
Pregnancy: Pregnancy Category C.
There are no adequate and well-controlled studies in pregnant women. It is not known whether ARIPIPRAZOLE can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. ARIPIPRAZOLE should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.
Labor and Delivery: The effect of aripiprazole on labor and delivery in humans is unknown.
Nursing Mothers: ARIPIPRAZOLE is present in human breast milk. Because of the potential for serious adverse reactions in nursing infants from ARIPIPRAZOLE, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
